{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:24:23Z","timestamp":1775705063981,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jad.2013.11.026","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T08:31:26Z","timestamp":1387269086000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Statins use and risk of depression: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"160","author":[{"given":"Ajay K.","family":"Parsaik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balwinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murad","family":"M. Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soniya S.","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Lapid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarrett W.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin P.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa A.","family":"Rummans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2013.11.026_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-2010-100180","article-title":"Statins and cognitive functioning in the elderly: a population-based study","volume":"21","author":"Benito-Len","year":"2010","journal-title":"J. Alzheimer's Dis."},{"issue":"11 Suppl. 2","key":"10.1016\/j.jad.2013.11.026_bib2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.amjmed.2008.09.010","article-title":"Depression in patients with coronary heart disease","volume":"121","author":"Carney","year":"2008","journal-title":"Am. J. Med."},{"issue":"9222","key":"10.1016\/j.jad.2013.11.026_bib3","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0140-6736(00)02400-4","article-title":"Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women","volume":"355","author":"Chan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2013.11.026_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2013.11.026_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"Coefficient of agreement for nominal scales educational and psychological measurement","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ. Psychol. Meas."},{"issue":"6824","key":"10.1016\/j.jad.2013.11.026_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/bmj.304.6824.431","article-title":"Should there be a moratorium on the use of cholesterol lowering drugs?","volume":"304","author":"Davey Smith","year":"1992","journal-title":"Br. Med. J."},{"issue":"3","key":"10.1016\/j.jad.2013.11.026_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controll. Clin. Trials"},{"issue":"24","key":"10.1016\/j.jad.2013.11.026_bib8","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1001\/jama.269.24.3107","article-title":"HMG CoA reductase inhibitors and quality of life","volume":"269","author":"Downs","year":"1993","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"20","key":"10.1016\/j.jad.2013.11.026_bib9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"8795","key":"10.1016\/j.jad.2013.11.026_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0140-6736(92)90609-7","article-title":"Low serum cholesterol and suicide","volume":"339","author":"Engelberg","year":"1992","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jad.2013.11.026_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.aje.a117465","article-title":"Plasma lipid levels and psychologic characteristics in men","volume":"141","author":"Freedman","year":"1995","journal-title":"Am. J. Epidemiol."},{"issue":"23","key":"10.1016\/j.jad.2013.11.026_bib12","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.CIR.98.23.2513","article-title":"Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators","volume":"98","author":"Goldberg","year":"1998","journal-title":"Circulation"},{"issue":"7309","key":"10.1016\/j.jad.2013.11.026_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/bmj.323.7309.375","article-title":"Risk of macular degeneration in users of statins: cross sectional study","volume":"323","author":"Hall","year":"2001","journal-title":"Br. Med. J."},{"issue":"3","key":"10.1016\/j.jad.2013.11.026_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2125.1994.tb04268.x","article-title":"Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers","volume":"37","author":"Harrison","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7414","key":"10.1016\/j.jad.2013.11.026_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.jad.2013.11.026_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01857703","article-title":"Serum cholesterol and aggression in hospitalized male forensic patients","volume":"18","author":"Hillbrand","year":"1995","journal-title":"J. Behav. Med."},{"issue":"9242","key":"10.1016\/j.jad.2013.11.026_bib17","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jad.2013.11.026_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.eurheartj.a060485","article-title":"Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study","volume":"15","author":"Keech","year":"1994","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.jad.2013.11.026_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1099-1557(199811\/12)7:6<399::AID-PDS385>3.0.CO;2-C","article-title":"Cholesterol-lowering drugs and antidepressantsa study of prescription symmetry","volume":"7","author":"Lindberg","year":"1998","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5542","key":"10.1016\/j.jad.2013.11.026_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1126\/science.294.5542.508","article-title":"Alzheimer's disease. Bad for the heart, bad for the mind?","volume":"294","author":"Marx","year":"2001","journal-title":"Science"},{"issue":"7319","key":"10.1016\/j.jad.2013.11.026_bib21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/bmj.323.7319.957","article-title":"Randomised trials of secondary prevention programmes in coronary heart disease: systematic review","volume":"323","author":"McAlister","year":"2001","journal-title":"Br. Med. J."},{"issue":"24","key":"10.1016\/j.jad.2013.11.026_bib22","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1001\/jama.283.24.3205","article-title":"HMG-CoA reductase inhibitors and the risk of fractures","volume":"283","author":"Meier","year":"2000","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"10.1016\/j.jad.2013.11.026_bib23","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"Br. Med. J."},{"issue":"9","key":"10.1016\/j.jad.2013.11.026_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7326\/0003-4819-121-9-199411010-00017","article-title":"Injury, death, and cholesterol","volume":"121","author":"Muldoon","year":"1994","journal-title":"Ann. Intern. Med."},{"issue":"6747","key":"10.1016\/j.jad.2013.11.026_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.301.6747.309","article-title":"Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials","volume":"301","author":"Muldoon","year":"1990","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jad.2013.11.026_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1741-7015-10-154","article-title":"The impact of statins on psychological wellbeing: a systematic review and meta-analysis","volume":"10","author":"ONeil","year":"2012","journal-title":"BMC Med."},{"issue":"6824","key":"10.1016\/j.jad.2013.11.026_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.304.6824.393","article-title":"Doubts about preventing coronary heart disease","volume":"304","author":"Oliver","year":"1992","journal-title":"Br. Med. J."},{"issue":"5","key":"10.1016\/j.jad.2013.11.026_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4088\/JCP.11m07038","article-title":"Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study","volume":"73","author":"Otte","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2013.11.026_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000319530","article-title":"Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression","volume":"79","author":"Pasco","year":"2010","journal-title":"Psychother. Psychosom."},{"issue":"18","key":"10.1016\/j.jad.2013.11.026_bib30","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/archinte.1996.00440170097011","article-title":"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study","volume":"156","author":"Pedersen","year":"1996","journal-title":"Arch. Intern. Med."},{"issue":"14","key":"10.1016\/j.jad.2013.11.026_bib31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jad.2013.11.026_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2013.11.026_bib33","first-page":"413","article-title":"Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression","volume":"8","author":"Santos","year":"2012","journal-title":"J. Neuropsychiatr. Dis. Treat."},{"issue":"8934","key":"10.1016\/j.jad.2013.11.026_bib34","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group.","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2013.11.026_bib35","first-page":"CD003160","article-title":"Statins for the reduction of risk of Alzheimer's disease","volume":"3","author":"Scott","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.jad.2013.11.026_bib36","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4088\/JCP.09m05825blu","article-title":"The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?","volume":"72","author":"Stafford","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2013.11.026_bib37","first-page":"92","article-title":"Cholesterol-lowering medication and relapse of depression","volume":"37","author":"Steffens","year":"2003","journal-title":"Psychopharmacol. Bull."},{"issue":"11","key":"10.1016\/j.jad.2013.11.026_bib38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.jad.2013.11.026_bib39","first-page":"435","article-title":"Serum cholesterol in aggressive conduct disorder: a preliminary study","volume":"19","author":"Virkkunen","year":"1984","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2013.11.026_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pneurobio.2009.02.002","article-title":"Statins: mechanisms of neuroprotection","volume":"88","author":"van der Most","year":"2009","journal-title":"Prog. Neurobiol."},{"issue":"24","key":"10.1016\/j.jad.2013.11.026_bib40","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1001\/jama.283.24.3211","article-title":"HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.","volume":"283","author":"Wang","year":"2000","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"7049","key":"10.1016\/j.jad.2013.11.026_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.313.7049.75","article-title":"Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group","volume":"313","author":"Wardle","year":"1996","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jad.2013.11.026_bib42","unstructured":"Wells Gas, B., OConnell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., 2013. The NewcastleOttawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. Available from: ?http:\/\/wwwohrica\/programs\/clinical_epidemiology\/oxfordasp? (accessed 19.02.13)."},{"issue":"1","key":"10.1016\/j.jad.2013.11.026_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejcnurse.2010.08.008","article-title":"The effects of statins on mood: a review of the literature","volume":"11","author":"While","year":"2012","journal-title":"Eur. J. Cardiovasc. Nurs.: J. Work. Group Cardiovasc. Nurs. Eur. Soc. Cardiol."},{"issue":"10","key":"10.1016\/j.jad.2013.11.026_bib44","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"issue":"16","key":"10.1016\/j.jad.2013.11.026_bib45","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/archinte.163.16.1926","article-title":"Lipid-lowering drugs and the risk of depression and suicidal behavior","volume":"163","author":"Yang","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.jad.2013.11.026_bib46","doi-asserted-by":"crossref","first-page":"153A-A","DOI":"10.1016\/S0735-1097(03)81758-8","article-title":"Long-term statin use and psychological well-being in the elderly","volume":"41","author":"Young-Xu","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.jad.2013.11.026_bib47","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What's the relative risk?A method of correcting the odds ratio in cohort studies of common outcomes","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA: J. Am. Med. Assoc."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032713008525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032713008525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:42:26Z","timestamp":1564965746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032713008525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":48,"alternative-id":["S0165032713008525"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2013.11.026","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins use and risk of depression: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2013.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}